Literature DB >> 19891491

Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.

Feng Liu1, Xin Chen, Abdellah Allali-Hassani, Amy M Quinn, Gregory A Wasney, Aiping Dong, Dalia Barsyte, Ivona Kozieradzki, Guillermo Senisterra, Irene Chau, Alena Siarheyeva, Dmitri B Kireev, Ajit Jadhav, J Martin Herold, Stephen V Frye, Cheryl H Arrowsmith, Peter J Brown, Anton Simeonov, Masoud Vedadi, Jian Jin.   

Abstract

SAR exploration of the 2,4-diamino-6,7-dimethoxyquinazoline template led to the discovery of 8 (UNC0224) as a potent and selective G9a inhibitor. A high resolution X-ray crystal structure of the G9a-8 complex, the first cocrystal structure of G9a with a small molecule inhibitor, was obtained. The cocrystal structure validated our binding hypothesis and will enable structure-based design of novel inhibitors. 8 is a useful tool for investigating the biology of G9a and its roles in chromatin remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19891491      PMCID: PMC2825141          DOI: 10.1021/jm901543m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 2.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 3.  The diverse functions of histone lysine methylation.

Authors:  Cyrus Martin; Yi Zhang
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

4.  Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.

Authors:  Stefan Kubicek; Roderick J O'Sullivan; E Michael August; Eugene R Hickey; Qiang Zhang; Miguel L Teodoro; Stephen Rea; Karl Mechtler; Jennifer A Kowalski; Carol Ann Homon; Terence A Kelly; Thomas Jenuwein
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

5.  A coupled fluorescent assay for histone methyltransferases.

Authors:  Evys Collazo; Jean-François Couture; Stacie Bulfer; Raymond C Trievel
Journal:  Anal Biochem       Date:  2005-07-01       Impact factor: 3.365

6.  A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors.

Authors:  Amy M Quinn; Abdellah Allali-Hassani; Masoud Vedadi; Anton Simeonov
Journal:  Mol Biosyst       Date:  2010-03-02

7.  Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9.

Authors:  Dorothea Greiner; Tiziana Bonaldi; Ragnhild Eskeland; Ernst Roemer; Axel Imhof
Journal:  Nat Chem Biol       Date:  2005-07-17       Impact factor: 15.040

Review 8.  The mammalian epigenome.

Authors:  Bradley E Bernstein; Alexander Meissner; Eric S Lander
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 9.  DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.

Authors:  Frank Lyko; Robert Brown
Journal:  J Natl Cancer Inst       Date:  2005-10-19       Impact factor: 13.506

10.  Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state.

Authors:  Kelly M McGarvey; Jill A Fahrner; Eriko Greene; Joost Martens; Thomas Jenuwein; Stephen B Baylin
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

View more
  82 in total

Review 1.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

2.  Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases.

Authors:  Yanqi Chang; Thota Ganesh; John R Horton; Astrid Spannhoff; Jin Liu; Aiming Sun; Xing Zhang; Mark T Bedford; Yoichi Shinkai; James P Snyder; Xiaodong Cheng
Journal:  J Mol Biol       Date:  2010-04-29       Impact factor: 5.469

Review 3.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

4.  Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

5.  Structure-activity relationship studies of G9a-like protein (GLP) inhibitors.

Authors:  Yan Xiong; Fengling Li; Nicolas Babault; Hong Wu; Aiping Dong; Hong Zeng; Xin Chen; Cheryl H Arrowsmith; Peter J Brown; Jing Liu; Masoud Vedadi; Jian Jin
Journal:  Bioorg Med Chem       Date:  2017-06-19       Impact factor: 3.641

6.  G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.

Authors:  Shih-Ting Cha; Ching-Ting Tan; Cheng-Chi Chang; Chia-Yu Chu; Wei-Jiunn Lee; Been-Zen Lin; Ming-Tsan Lin; Min-Liang Kuo
Journal:  Nat Cell Biol       Date:  2016-08-15       Impact factor: 28.824

7.  An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

Authors:  Kyle D Konze; Anqi Ma; Fengling Li; Dalia Barsyte-Lovejoy; Trevor Parton; Christopher J Macnevin; Feng Liu; Cen Gao; Xi-Ping Huang; Ekaterina Kuznetsova; Marie Rougie; Alice Jiang; Samantha G Pattenden; Jacqueline L Norris; Lindsey I James; Bryan L Roth; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Klaus M Hahn; Gang Greg Wang; Masoud Vedadi; Jian Jin
Journal:  ACS Chem Biol       Date:  2013-04-24       Impact factor: 5.100

Review 8.  Biophysical characterization of recombinant proteins: a key to higher structural genomics success.

Authors:  Masoud Vedadi; Cheryl H Arrowsmith; Abdellah Allali-Hassani; Guillermo Senisterra; Gregory A Wasney
Journal:  J Struct Biol       Date:  2010-05-11       Impact factor: 2.867

9.  Structural genomics of histone tail recognition.

Authors:  Minghua Wang; Man Wai Mok; Hong Harper; Wen Hwa Lee; Jinrong Min; Stefan Knapp; Udo Oppermann; Brian Marsden; Matthieu Schapira
Journal:  Bioinformatics       Date:  2010-08-24       Impact factor: 6.937

10.  Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors.

Authors:  Feng Liu; Fengling Li; Anqi Ma; Elena Dobrovetsky; Aiping Dong; Cen Gao; Ilia Korboukh; Jing Liu; David Smil; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Matthieu Schapira; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2013-02-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.